Notifications of suspensions

General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0338 can be found here:

Documents and Forms

Document Name Document Type
Form 356h Notifications of suspensions Form and Instruction
356h Application to Market a New Drug or Biologic for Human U FORM FDA 356h revised 2-28-14.pdf Form and Instruction

Information Collection (IC) Details

IC Title:	Notifications of suspensions	Agency IC Tracking Number:

Is this a Common Form? No		IC Status: Modified

Obligation to Respond: Mandatory

CFR Citation: 21 CFR 601.6(a)

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form and Instruction	356h	Application to Market a New Drug or Biologic for Human Use	FORM FDA 356h revised 2-28-14.pdf		Yes	Yes	Fillable Printable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 1	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 100 %

	Approved	Change Due to Adjustment in Agency Estimate	Previously Approved
Annual Number of Responses for this IC	20	-2,757	2,777
Annual IC Time Burden (Hours)	7	-55,533	55,540
Annual IC Cost Burden (Dollars)	924	924	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.